Fujian Cosunter Pharmaceutical Hits Day Low at CNY 103 Amid Price Pressure

Fujian Cosunter Pharmaceutical Co., Ltd. experienced a significant decline today, with the stock dropping by 7.73% to reach an intraday low of CNY 103.00. This performance stands in contrast to the China Shanghai Composite, which fell by only 1.24% on the same day. Over the past week, Fujian Cosunter has seen a slight decrease of 1.11%, while its monthly performance reflects a more substantial decline of 16.15%. Despite a remarkable annual return of 180.15%, the company faces challenges, including operating losses and a weak long-term fundamental strength. The net profit for the half-year period reported a loss of CNY 83.1 million, marking a decline of 48.39%. Additionally, the company's return on capital employed (ROCE) is notably low at -47.59%, and its inventory turnover ratio stands at just 1.33 times. Fujian Cosunter's market capitalization is approximately CNY 16,397 million, categorizing it as a large-cap company. The stock's high debt-to-equity ratio of 0.50 further underscores the financial pressures it faces within the competitive pharmaceuticals and biotechnology industry.